SILO PHARMA, INC. Preferred Stock, Capital Shares Reserved for Future Issuance
SILO PHARMA, INC. (SILO) had Preferred Stock, Capital Shares Reserved for Future Issuance of 15.13 thousand shares as of 2021-12-31, per its 10-K filed 2023-03-24.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockCapitalSharesReservedForFutureIssuance · last filed 2023-03-24
- 2021-12-31: Preferred Stock, Capital Shares Reserved for Future Issuance 15.13K shares.
| Period end | Preferred Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2021-12-31 | 15.13K shares 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |